Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-03

Clinical Trial Update: Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis [EARLY_Phase 1]

View source ↗

Summary

This EARLY Phase 1 trial compares two PET tracers, [18F]AlF-PSMA-N5 and [18F]F-DCFPyL, for diagnosing, monitoring recurrence, and detecting metastasis in prosta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • [18F]AlF-PSMA-N5 (18F-AlF-PSMA-N5)
  • [18F]F-DCFPyL (18F-DCFPyL)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Prostate Cancer, PET/CT | EARLY_Phase 1 | Status: RECRUITING